Evolent Health, Inc. - EVH

EVH Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EVH	-2.3	-14.0	-53.1	-54.5	-47.4	-58.3	-55.1	30.3	-34.4	-34.4
S&P 500	-1.3	-1.8	1.0	5.9	10.6	30.4	25.4	88.1	187.6	33142.5

Compare EVH with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EVH
name	Evolent Health, Inc.
price	12.38
changes percentage	-2.2889
change	-0.29
day low	12.18
day high	12.81
year high	35
year low	12.18
market cap	1443062320
price avg 50	25.4672
price avg 200	26.56505
exchange	NYSE
volume	3122739
avg volume	2406553
open	12.81
previous close	12.67
eps	-0.92
pe	-13.46
earnings announcement	2025-02-19T12:00:00.000+0000
shares outstanding	116564000
timestamp	2024-11-15 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.0%

Overall Quarterly Financial Health: 28.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001628908
revenue	1963896000	1352013000	45.26
gross profit	460470000	316584000	45.45
gross profit ratio	0.23	0.23	0.13
research and development expenses	0	27000000	-100.00
operating expenses	531681000	336464000	58.02
interest income	5256000	1369000	283.93
interest expense	54205000	15572000	248.09
ebitda	-24785000	43746000	-156.66
ebitdaratio	-0.01	0.01	-331.83
operating income	-71211000	-59835000	-19.01
operating income ratio	-0.04	-0.04	18.07
net income	-113040000	-18701000	-504.46
net income ratio	-0.06	-0.01	-316.13
eps	-1.28	-0.2	-540.00

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,964 million in 2023 from 1,352 million in 2022 representing a change of 45.26%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 460 million in 2023 from 317 million in 2022 representing a change of 45.45%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to -71 million in 2023 from -60 million in 2022 representing a change of -19.01%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 27 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 532 million in 2023 from 336 million in 2022 representing a change of 58.02%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -25 million in 2023 from 44 million in 2022 representing a change of -156.66%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to -113 million in 2023 from -19 million in 2022 representing a change of -504.46%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -1.28 in 2023 from -1.28 in 2022 representing a change of -540.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001628908
revenue	621401000	647145000	-3.98
gross profit	80693000	76673000	5.24
gross profit ratio	0.13	0.12	9.60
research and development expenses	0	6700000	-100.00
operating expenses	96961000	67215000	44.26
interest income	794000	1370000	-42.04
interest expense	6010000	5995000	0.25
ebitda	11955000	40442000	-70.44
ebitdaratio	0.02	0.06	-69.21
operating income	-16268000	9458000	-272.00
operating income ratio	-0.03	0.01	-279.13
net income	-23137000	1596000	-1549.69
net income ratio	-0.04	0.0	-1609.75
eps	-0.27	-0.06	-384.74

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 621 million in 2024Q3 from 647 million in 2024Q2 representing a change of -3.98%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 7 million in 2024Q2 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 97 million in 2024Q3 from 67 million in 2024Q2 representing a change of 44.26%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 12 million in 2024Q3 from 40 million in 2024Q2 representing a change of -70.44%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -16 million in 2024Q3 from 9 million in 2024Q2 representing a change of -272.0%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -23 million in 2024Q3 from 2 million in 2024Q2 representing a change of -1549.69%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.27 in 2024Q3 from -0.27 in 2024Q2 representing a change of -384.74%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 81 million in 2024Q3 from 77 million in 2024Q2 representing a change of 5.24%. This indicates a sales profitability growth, which is a positive sign for the company.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001628908
total assets	2680308000	1817293000	47.49
total liabilities	1612607000	957876000	68.35
total equity	1067701000	859417000	24.24
cash and cash equivalents	192825000	188200000	2.46
short term investments	13768000	14492000	-5.00
long term investments	4895000	4475000	9.39
total current assets	683673000	478054000	43.01
total non current assets	1996635000	1339239000	49.09
total current liabilities	674242000	433442000	55.56
total non current liabilities	938365000	524434000	78.93
common stock	1154000	1015000	13.69
retained earnings	-719194000	-606154000	-18.65
total debt	644796000	476118000	35.43

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,680 million in 2023 from 1,817 million in 2022 representing a change of 47.49%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,068 million in 2023 from 859 million in 2022 representing a change of 24.24%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 193 million in 2023 from 188 million in 2022 representing a change of 2.46%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 684 million in 2023 from 478 million in 2022 representing a change of 43.01%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 13.69%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,613 million in 2023 from 958 million in 2022 representing a change of 68.35%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 14 million in 2023 from 14 million in 2022 representing a change of -5.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 674 million in 2023 from 433 million in 2022 representing a change of 55.56%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -719 million in 2023 from -606 million in 2022 representing a change of -18.65%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 645 million in 2023 from 476 million in 2022 representing a change of 35.43%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001628908
total assets	2501764000	2475109000	1.08
total liabilities	1275913000	1421248000	-10.23
total equity	1038685000	1053861000	-1.44
cash and cash equivalents	96583000	121303000	-20.38
short term investments	16343000	20053000	-18.50
long term investments	8405000	25017000	-66.40
total current assets	544011000	520971000	4.42
total non current assets	1957753000	1954138000	0.18
total current liabilities	523683000	483374000	8.34
total non current liabilities	752230000	937874000	-19.79
common stock	1166000	1163000	0.26
retained earnings	-758015000	-734878000	-3.15
total debt	635206000	819912000	-22.53

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,502 million in 2024Q3 from 2,475 million in 2024Q2 representing a change of 1.08%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 1,276 million in 2024Q3 from 1,421 million in 2024Q2 representing a change of -10.23%. This indicates a decrease in overall liabilities.

  Total Current Assets: Total Current Assets increased to 544 million in 2024Q3 from 521 million in 2024Q2 representing a change of 4.42%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2024Q3 from 1 in 2024Q2 representing a change of 0.26%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 635 million in 2024Q3 from 820 million in 2024Q2 representing a change of -22.53%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Equity: Total Equity decreased to 1,039 million in 2024Q3 from 1,054 million in 2024Q2 representing a change of -1.44%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 97 million in 2024Q3 from 121 million in 2024Q2 representing a change of -20.38%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 16 million in 2024Q3 from 20 million in 2024Q2 representing a change of -18.5%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 524 million in 2024Q3 from 483 million in 2024Q2 representing a change of 8.34%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -758 million in 2024Q3 from -735 million in 2024Q2 representing a change of -3.15%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001628908
net change in cash	8299000	-139784000	105.94
operating cash flow	142582000	-11553000	1334.16
free cash flow	113837000	-49914000	328.07
capital expenditure	-28745000	-38361000	25.07
depreciation and amortization	123415000	67195000	83.67
deferred income tax	-31272000	342000	-9243.86
stock based compensation	40501000	33981000	19.19
accounts payables	-6723000	13165000	-151.07
inventory	-10746000	0	NaN
acquisitions net	0	5552000	-100.00
investments in property plant and equipment	-28745000	-38361000	25.07
net cash used for investing activites	-415544000	-259115000	-60.37
debt repayment	183293000	160291000	14.35
common stock issued	0	4452000	-100.00
common stock repurchased	0	-18318000	100.00
dividends paid	-18793000	-14884000	-26.26
net cash used provided by financing activities	281340000	131541000	113.88
cash at end of period	223457000	215158000	3.86
accounts receivables	-164694000	-102980000	-59.93
cash at beginning of period	215158000	354942000	-39.38

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 8 million in 2023 from -140 million in 2022 representing a change of 105.94%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 143 million in 2023 from -12 million in 2022 representing a change of 1334.16%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 114 million in 2023 from -50 million in 2022 representing a change of 328.07%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 7 million in 2023 from 13 million in 2022 representing a change of -151.07%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -165 million in 2023 from -103 million in 2022 representing a change of -59.93%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -29 million in 2023 from -38 million in 2022 representing a change of 25.07%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 41 million in 2023 from 34 million in 2022 representing a change of 19.19%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -19 million in 2023 from -15 million in 2022 representing a change of -26.26%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001628908
operating cash flow	18670000	21417000	-12.83
free cash flow	12381000	14311000	-13.49
capital expenditure	-6289000	-7106000	11.50
depreciation and amortization	32191000	30984000	3.90
deferred income tax	-937000	-1160000	19.22
stock based compensation	14416000	12659000	13.88
accounts receivables	-34177000	54012000	-163.28
accounts payables	16590000	-6909000	340.12
inventory	0	0	NaN
acquisitions net	5947000	-4562000	230.36
investments in property plant and equipment	-6289000	-7106000	11.50
net cash used for investing activites	-19729000	-13541000	-45.70
debt repayment	0	0	NaN
common stock issued	-1119000	61000	-1934.43
common stock repurchased	14698000	-364000	4137.91
dividends paid	-5134000	-5067000	-1.32
net cash used provided by financing activities	-9008000	-103381000	91.29
net change in cash	-10098000	-95438000	89.42
cash at end of period	127851000	121303000	5.40
cash at beginning of period	137949000	216741000	-36.35

Overall Score of Quarterly Cashflow Statement

0.22 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -10 million in 2024Q3 from -95 million in 2024Q2 representing a change of 89.42%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to -34 million in 2024Q3 from 54 million in 2024Q2 representing a change of -163.28%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 19 million in 2024Q3 from 21 million in 2024Q2 representing a change of -12.83%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 12 million in 2024Q3 from 14 million in 2024Q2 representing a change of -13.49%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -6 million in 2024Q3 from -7 million in 2024Q2 representing a change of 11.5%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 19.22%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 14 million in 2024Q3 from 13 million in 2024Q2 representing a change of 13.88%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 17 million in 2024Q3 from 7 million in 2024Q2 representing a change of 340.12%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -5 million in 2024Q3 from -5 million in 2024Q2 representing a change of -1.32%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	17.65	14.43	22.34
net income per share	-1.02	-0.2	-409.09
operating cash flow per share	1.28	-0.12	1139.44
free cash flow per share	1.02	-0.53	292.08
cash per share	1.86	2.16	-14.16
book value per share	9.6	9.17	4.63
tangible book value per share	-7.2	-3.27	-120.32
shareholders equity per share	9.6	9.17	4.63
interest debt per share	5.94	4.65	27.78
market cap	3674620530	2631067920	39.66
enterprise value	4126591530	2918985920	41.37
pe ratio	-32.51	-140.69	76.89
price to sales ratio	1.87	1.95	-3.85
pocfratio	25.77	-227.74	111.32
pfcf ratio	32.28	-52.71	161.24
pb ratio	3.44	3.06	12.42
ptb ratio	3.44	3.06	12.42
ev to sales	2.1	2.16	-2.68
enterprise value over ebitda	-166.5	66.73	-349.52
ev to operating cash flow	28.94	-252.66	111.45
ev to free cash flow	36.25	-58.48	161.99
earnings yield	-0.03	-0.01	-332.80
free cash flow yield	0.03	-0.02	263.30
debt to equity	0.57	0.49	16.26
debt to assets	0.23	0.23	-2.07
net debt to ebitda	-18.24	6.58	-377.07
current ratio	1.01	1.1	-8.06
interest coverage	-1.31	-3.84	65.81
income quality	-1.26	0.6	-309.23
dividend yield	0.01	0.01	-9.59
payout ratio	-0.17	-0.8	79.11
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.02	-100.00
intangibles to total assets	0.7	0.64	8.70
capex to operating cash flow	0.2	-3.32	106.07
capex to revenue	0.01	0.03	-48.41
capex to depreciation	0.23	0.57	-59.20
stock based compensation to revenue	0.02	0.03	-17.95
graham number	14.81	6.42	130.80
roic	-0.02	-0.01	-68.59
return on tangible assets	-0.14	-0.03	-385.30
graham net net	-9.63	-8.24	-16.82
working capital	9431000	44612000	-78.86
tangible asset value	-800850000	-306141000	-161.60
net current asset value	-928934000	-479822000	-93.60
invested capital	1968159000	1347071000	46.11
average receivables	350716500	192644000	82.05
average payables	52710000	76629000	-31.21
average inventory	-207963000	-362074000	42.56
days sales outstanding	83.03	68.76	20.76
days payables outstanding	11.71	20.15	-41.88
days of inventory on hand	0	-146.62	100.00
receivables turnover	4.4	5.31	-17.19
payables turnover	31.16	18.11	72.07
inventory turnover	0	-2.49	100.00
roe	-0.11	-0.02	-386.54
capex per share	0.26	0.41	-36.89

• Negative

  ROE: Return on Equity (ROE) decreased to -0.11 on 2023-12-31 from -0.02 on 2022-12-31, representing a change of -386.54%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -32.51 on 2023-12-31 from -140.69 on 2022-12-31, representing a change of 76.89%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.01 on 2023-12-31 from 1.10 on 2022-12-31, representing a change of -8.06%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.57 on 2023-12-31 from 0.49 on 2022-12-31, representing a change of 16.26%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
EVH
calendar year	2024	2024	NaN
revenue per share	5.41	5.64	-4.12
net income per share	-0.2	0.01	-1547.49
operating cash flow per share	0.16	0.19	-12.96
free cash flow per share	0.11	0.12	-13.62
cash per share	0.98	1.23	-20.23
book value per share	10.67	9.19	16.14
tangible book value per share	-5.3	-6.75	21.53
shareholders equity per share	9.04	9.19	-1.59
interest debt per share	5.53	5.6	-1.19
market cap	3248297360	2111406080	53.85
enterprise value	3786920360	2810015080	34.77
pe ratio	-35.1	330.73	-110.61
price to sales ratio	5.23	3.26	60.22
pocfratio	173.98	98.59	76.48
pfcf ratio	262.36	147.54	77.83
pb ratio	3.13	2.0	56.09
ptb ratio	3.13	2.0	56.09
ev to sales	6.09	4.34	40.35
enterprise value over ebitda	316.76	69.48	355.89
ev to operating cash flow	202.83	131.2	54.59
ev to free cash flow	305.87	196.35	55.77
earnings yield	-0.01	0.0	-1042.30
free cash flow yield	0.0	0.01	-43.77
debt to equity	0.61	0.6	0.39
debt to assets	0.25	0.26	-2.11
net debt to ebitda	45.05	17.27	160.82
current ratio	1.04	1.08	-3.62
interest coverage	-2.71	1.58	-271.57
income quality	-0.81	13.42	-106.01
dividend yield	0.0	0.0	-34.14
payout ratio	-0.22	3.17	-106.99
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.73	0.74	-0.72
capex to operating cash flow	0.34	0.33	1.52
capex to revenue	0.01	0.01	-7.83
capex to depreciation	0.2	0.23	-14.82
stock based compensation to revenue	0.02	0.02	18.60
graham number	6.4	1.7	277.42
roic	-0.01	0.01	-244.41
return on tangible assets	-0.03	0.0	-1505.47
graham net net	-7.38	-8.72	15.38
working capital	20328000	37597000	-45.93
tangible asset value	-608270000	-773967000	21.41
net current asset value	-731902000	-900277000	18.70
invested capital	1937634000	1950627000	-0.67
average receivables	397415000	400732000	-0.83
average payables	44558500	58188000	-23.42
average inventory	0	0	NaN
days sales outstanding	60.99	51.97	17.35
days payables outstanding	8.34	6.16	35.39
days of inventory on hand	0	0	NaN
receivables turnover	1.48	1.73	-14.78
payables turnover	10.8	14.62	-26.14
inventory turnover	0	0	NaN
roe	-0.02	0.0	-1570.87
capex per share	0.05	0.06	-11.63

• Negative

  ROE: Return on Equity (ROE) decreased to -0.02 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of -1570.87%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -35.10 on 2024-09-30 Q3 from 330.73 on 2024-06-30 Q2, representing a change of -110.61%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.04 on 2024-09-30 Q3 from 1.08 on 2024-06-30 Q2, representing a change of -3.62%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.61 on 2024-09-30 Q3 from 0.60 on 2024-06-30 Q2, representing a change of 0.39%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None